Literature DB >> 26546575

DFL23448, A Novel Transient Receptor Potential Melastin 8-Selective Ion Channel Antagonist, Modifies Bladder Function and Reduces Bladder Overactivity in Awake Rats.

Francesco A Mistretta1, Andrea Russo1, Fabio Castiglione1, Arianna Bettiga1, Giorgia Colciago1, Francesco Montorsi1, Laura Brandolini1, Andrea Aramini1, Gianluca Bianchini1, Marcello Allegretti1, Silvia Bovolenta1, Roberto Russo1, Fabio Benigni1, Petter Hedlund2.   

Abstract

The transient receptor potential melastin 8 ion channel (TRPM8) is implicated in bladder sensing but limited information on TRPM8 antagonists in bladder overactivity is available. This study characterizes a new TRPM8-selective antagonist (DFL23448 [5-(2-ethyl-2H-tetrazol-5-yl)-2-(3-fluorophenyl)-1,3-thiazol-4-ol]) and evaluates it in cold-induced behavioral tests and tests on bladder function and experimental bladder overactivity in vivo in rats. DFL23448 displayed IC50 values of 10 and 21 nM in hTRPM8 human embryonic kidney 293 cells activated by Cooling Agent 10 or cold, but it had limited activity (IC50 > 10 μM) at transient receptor potential vanilloids TRPV1, TRPA1, or TRPV4 or at various G protein-coupled receptors. In rats, DFL23448 administered intravenously or orally had a half-life of 37 minutes or 4.9 hours, respectively. DLF23448 (10 mg/kg i.v.) reduced icilin-induced "wet dog-like" shakes in rats. Intravesical DFL23448 (10 mg/l), but not vehicle, increased micturition intervals, micturition volume, and bladder capacity. During bladder overactivity by intravesical prostaglandin E2 (PGE2), vehicle controls exhibited reductions in micturition intervals, micturition volumes, and bladder capacity by 37%-39%, whereas the same parameters only decreased by 12%-15% (P < 0.05-0.01 versus vehicle) in DFL23448-treated rats. In vehicle-treated rats, but not in DFL23448-treated rats, intravesical PGE2 increased bladder pressures. Intravenous DFL23448 at 10 mg/kg, but not 1 mg/kg DFL23448 or vehicle, increased micturition intervals, micturition volumes, and bladder capacity. During bladder overactivity by intravesical PGE2, micturition intervals, micturition volumes, and bladder capacity decreased in vehicle- and 1 mg/kg DFL23448-treated rats, but not in 10 mg/kg DFL23448-treated rats. Bladder pressures increased less in rats treated with DFL23448 10 mg/kg than in vehicle- or 1 mg/kg DFL23448-treated rats. DFL23448 (10 mg/kg i.v.), but not vehicle, prevented cold stress-induced bladder overactivity. Our results support a role for bladder TRPM8-mediated signals in experimental bladder overactivity.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26546575     DOI: 10.1124/jpet.115.228684

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

Review 1.  TRPM8 and Migraine.

Authors:  Greg Dussor; Yu-Qing Cao
Journal:  Headache       Date:  2016-09-16       Impact factor: 5.887

2.  TRPM8 channel activation triggers relaxation of pudendal artery with increased sensitivity in the hypertensive rats.

Authors:  Darizy Flavia Silva; Camilla Ferreira Wenceslau; Cameron G Mccarthy; Theodora Szasz; Safia Ogbi; R Clinton Webb
Journal:  Pharmacol Res       Date:  2019-07-21       Impact factor: 7.658

3.  Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat.

Authors:  Carmen De Caro; Roberto Russo; Carmen Avagliano; Claudia Cristiano; Antonio Calignano; Andrea Aramini; Gianluca Bianchini; Marcello Allegretti; Laura Brandolini
Journal:  Br J Pharmacol       Date:  2018-04-14       Impact factor: 8.739

4.  Catalyst-Free Synthesis of Polysubstituted 5-Acylamino-1,3-Thiazoles via Hantzsch Cyclization of α-Chloroglycinates.

Authors:  Mara Tomassetti; Gabriele Lupidi; Pamela Piermattei; Federico V Rossi; Samuele Lillini; Gianluca Bianchini; Andrea Aramini; Marco A Ciufolini; Enrico Marcantoni
Journal:  Molecules       Date:  2019-10-25       Impact factor: 4.411

5.  Therapeutic potential of TRPM8 antagonists in prostate cancer.

Authors:  Marzia Di Donato; Carmine Ostacolo; Pia Giovannelli; Veronica Di Sarno; Isabel M Gomez Monterrey; Pietro Campiglia; Antimo Migliaccio; Alessia Bertamino; Gabriella Castoria
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

Review 6.  The TRPM8 channel as a potential therapeutic target for bladder hypersensitive disorders.

Authors:  Naoki Aizawa; Tomoe Fujita
Journal:  J Smooth Muscle Res       Date:  2022
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.